Hepatitis D, or viral hepatitis caused by the HDV virus, is a special form of hepatitis that requires the presence of the hepatitis B virus for its replication. This virus was discovered in 1977 and is now considered a co-infection that significantly worsens the course of liver disease caused by the hepatitis B virus. Hepatitis D is one of the most severe forms of hepatitis, as it can lead to acute and chronic liver disease, which is associated with a high risk of developing cirrhosis and hepatocellular carcinoma.
History of the disease and interesting historical facts
The hepatitis D virus was first isolated in 1977 by a group of scientists led by the Italian physician and virologist Professor Alberto Montanari. The emergence of this virus was associated with the observation of high levels of morbidity in regions with widespread chronic hepatitis B infection. An interesting fact is that HDV cannot exist independently, and its infectivity depends on the presence of the hepatitis B virus. As hepatitis science has developed, the hepatitis D virus has become the subject of many epidemiological studies aimed at understanding its mechanisms of action, pathogenesis, and methods of prevention.
Epidemiology
According to the latest data from the World Health Organization (WHO), the prevalence of hepatitis D varies in different regions of the world and depends on the incidence of hepatitis B. In some countries, especially in West Africa and parts of South America, rates can reach 5-25% among people infected with the hepatitis B virus. In some Caucasian populations, the hepatitis D carriage rate ranges from 1 to 5%. The disease is more common among younger people, including people who inject drugs, making the issue particularly relevant for public health.
Genetic predisposition to this disease
To date, certain genetic markers have been studied that may predispose to a more severe form of hepatitis D. In particular, genes responsible for the immune response, such as HLA, show a significant impact on the course of the disease. Mutations in genes associated with the regulation of inflammatory processes may increase the risk of disease progression and chronicity. Studies show that specific alleles of HLA-B*35:01 may be associated with a higher risk of hepatitis D in people with other genetic diversity.
Risk factors for the development of this disease
Risk factors associated with hepatitis D include:
- Co-infection with hepatitis B virus (HBV).
- Injection drug use.
- Unsustainable medical practices such as unsterile needles and instruments.
- Transmission of the virus from mother to child during childbirth.
- Limited access to health services and awareness of the condition.
These factors combine to create individual risks and determine the spread of the virus in the population.
Diagnosis of this disease
Diagnosis of hepatitis D begins with a clinical examination of the patient and an analysis of his medical history. The main symptoms of the disease may include:
- Fatigue and weakness.
- Nausea and vomiting.
- Pain in the liver area.
- Darkening of urine and discoloration of stool.
- Jaundice.
Laboratory tests include serologic tests to detect HDV-related antibodies and antigens, and blood chemistry tests to evaluate liver function. Radiologic tests such as ultrasound and CT scans help visualize the liver and identify possible complications. Differential diagnosis is performed to exclude other types of hepatitis and liver diseases.
Treatment
Treatment of hepatitis D includes several approaches, depending on the stage of the disease:
- General treatment involves maintaining a normal lifestyle, avoiding alcohol and eating a balanced diet.
- Pharmacological treatment includes the use of interferons and newer antiviral drugs such as nucleoside analogues.
- Surgical treatment is required if complications such as cirrhosis develop and may include liver transplantation.
- Other treatments may include immunotherapy and rehabilitation programs.
List of medications used to treat this disease
There are a number of drugs used in the treatment of hepatitis D:
- Interferon alpha-2a and alpha-2b.
- Lamivudine.
- Adefovir.
- Tenofovir.
- Sofosbuvir.
Each of these drugs has unique mechanisms of action and is used depending on the specific indications and the patient's condition.
Disease monitoring
Monitoring of hepatitis D involves regular follow-up examinations of liver function and viral load. Prognosis depends on many factors, including the extent of liver damage and response to treatment. Complications such as cirrhosis and hepatocellular carcinoma significantly worsen the prognosis and require prompt intervention.
Age-related features of the disease
In children, hepatitis D may be less aggressive, but it often goes unnoticed until serious complications develop. In adults, the disease manifests itself more acutely with pronounced symptoms. Older people may have a more protracted course of the disease, which is associated with metabolic characteristics and the presence of concomitant diseases.
Questions and Answers
- How is hepatitis D transmitted? Hepatitis D is transmitted through contact with infected blood, sexually, and from mother to child during childbirth.
- Can Hepatitis D be prevented? Yes, prevention of hepatitis D includes hepatitis B vaccination and avoiding direct contact with infected blood.
- What is the relationship between hepatitis D and hepatitis B? The hepatitis D virus can only replicate in the presence of the hepatitis B virus, making this infection a coinfection.
- How often should you be tested for hepatitis D? Laboratory tests should be performed regularly, at least every 3-6 months, depending on the severity of the disease.
- How effective is hepatitis D treatment? Treatment success may vary, but early diagnosis and appropriate treatment can significantly improve a patient's prognosis.
Dr. Oleg Korzhikov recommends paying attention to the main symptoms of hepatitis D and, if there is any suspicion, immediately seek medical help. It is important to remember that hepatitis D is a serious disease that requires a comprehensive approach to diagnosis and treatment. He also emphasizes the importance of vaccination against hepatitis B as the main method of preventing hepatitis D, since this measure can significantly reduce the risk of infection in vulnerable groups of the population.
